Lenostella

Levonorgestrel, the active ingredient in Lenostella, is a synthetic progestin presented as a tablet for oral use. It works by inhibiting ovulation, thickening cervical mucus, and altering the endometrial lining, thereby preventing fertilisation and implantation. The medication is indicated for emergency contraception after unprotected intercourse and for ongoing hormonal birth control in women of reproductive age.

GNH USA supplies Lenostella as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lenostella (levonorgestrel) acts on the hormonal reproductive pathway to provide contraceptive effects.

Emergency contraception: prevents pregnancy when taken shortly after unprotected intercourse Routine hormonal contraception: provides ongoing birth control for women of child‑bearing age Ovulation suppression: blocks the release of an egg during the menstrual cycle

Levonorgestrel may cause a range of adverse reactions, which are generally classified by frequency.

Common Side Effects: - Nausea - Headache - Breast tenderness - Abdominal pain - Menstrual changes (spotting or delayed bleeding) - Fatigue

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Severe abdominal pain - Chest pain or palpitations - Blood clots (deep vein thrombosis, pulmonary embolism) - Liver dysfunction (jaundice, elevated enzymes)

Before using Lenostella, several precautionary measures should be considered to ensure safe and effective use.

Pregnancy testing: confirm the patient is not already pregnant Contraindications: avoid in individuals with known hypersensitivity to levonorgestrel Medical history: assess for thromboembolic disorders, liver disease, or hormone‑sensitive cancers Drug interactions: review concomitant medications that may affect efficacy Store below 25°C: keep in the original pack, protect from moisture

Levonorgestrel can interact with other medicines, influencing its contraceptive effectiveness.

Major Interactions (Avoid): - Combined hormonal contraceptives: concurrent use may increase hormonal load - Strong enzyme inducers (e.g., rifampicin, carbamazepine, phenytoin): may markedly reduce levonorgestrel levels

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may modestly decrease effectiveness - Certain antibiotics (e.g., ampicillin): possible reduced efficacy - Herbal supplements such as St. John’s wort: may lower plasma concentrations